Irritable Bowel Syndrome, COVID and the Gut Microbiome – The Latest Research and Implications for Clinical Practice With Dr Imran Aziz
Dr Imran Aziz is a Senior Clinical Lecturer and Honorary Consultant Gastroenterologist in Sheffield. In addition to his clinical work, Dr Aziz is a co-author on the British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (IBS) and functional dyspepsia.Dr Imran Aziz is a Senior Clinical Lecturer and In this webinar, Dr Aziz provides an overview of COVID-19 and its impact on disorders of gut–brain interaction, exploring what recent evidence tells us about the connections between viral infection, the microbiome, and gastrointestinal symptoms. He then discusses the role of probiotics as part of a holistic management approach for IBS symptoms, including the latest data on their effectiveness and mechanisms of action. Finally, Dr Aziz shares some preliminary findings from his own research, highlighting potential considerations and implications for clinical practice in the wake of COVID-19.
Learning Objectives:
By the end of this session, participants will be able to define disorders of gut–brain interaction (DGBIs) and describe the relationship between COVID-19 and DGBIs
Recommended for you…
CPD e-learning
0.5 CPD learning hour
CPD e-learning
1 CPD learning hour
Webinar on Demand
0.5 CPD learning hour
Clinical Summary
~5 minute read